Drug name - Morphine Sulfate

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9248229 FRESENIUS KABI USA Packaging system for oxygen-sensitive drugs Mar, 2034

(11 years from now)

US9192608 FRESENIUS KABI USA Morphine formulations Mar, 2034

(11 years from now)

US9072781 FRESENIUS KABI USA Morphine formulations Mar, 2034

(11 years from now)

Drugs and Companies using MORPHINE SULFATE ingredient

Treatment: Management of chronic pain in patients requiring opioid analgesia; treatment of pain

Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
2MG/ML (2MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription
4MG/ML (4MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription
5MG/ML (5MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription
8MG/ML (8MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription
10MG/ML (10MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.